Ignite Creation Date:
2024-05-05 @ 12:01 PM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00210106
Status:
COMPLETED
Last Update Posted:
2021-05-18
First Post:
2005-09-12
Brief Title:
Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection With or Without Neoadjuvant Chemotherapy
Sponsor:
Institut Bergonié
Organization:
Institut Bergonié
Study Overview
Official Title:
Treatment of Unresectable Colorectal Metastases by Radiofrequency Ablation Combined or Not With Resection With or Without Neoadjuvant Chemotherapy A Phase 2 Study
Status:
COMPLETED
Status Verified Date:
2021-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ARF2003
Brief Summary:
The hypothesis is that radiofrequency ablation combined or not with resection may allow a local control the liver in patients suffering from unresectable colorectal liver metastases Patients may have benefit or not from a preoperative neoadjuvant chemotherapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| ARF2003 | None | None | None |